Inventor · disambiguated record
Jason G. Lewis
Also filed as: LEWIS JASON · LEWIS JASON G · LEWIS JASON GUSTAF · LEWIS JASON T
39 granted patents·27 pending applications·271 citations·filing 1994–2025
97Inventor score
Files withARDELYX INC42VICURON PHARM INC8LYCIA THERAPEUTICS INC7GILEAD SCIENCES INC2CHARMOT DOMINIQUE1
Top patents by PatentIndex Score
66 records- 0194US5777153ACationic lipidsGILEAD SCIENCES INC·Filed 1994·Granted Jul 7, 1998·123 cites·20 claims
- 0291US10793568B2Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2017·Granted Oct 6, 2020·4 cites·1 claims
- 0388US7361743B2Lincomycin derivatives possessing antibacterial activityPFIZER·Filed 2005·Granted Apr 22, 2008·12 cites·25 claims
- 0487US11242337B2Compounds useful for treating gastrointestinal tract disordersARDELYX INC·Filed 2018·Granted Feb 8, 2022·3 cites·20 claims
- 0587US10376481B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2017·Granted Aug 13, 2019·3 cites·32 claims
- 0686US10968246B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2019·Granted Apr 6, 2021·2 cites·27 claims
- 0786US8916569B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Dec 23, 2014·7 cites·44 claims
- 0886US8809339B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 19, 2014·8 cites·36 claims
- 0986US6987104B2Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of useVICURON PHARM INC·Filed 2002·Granted Jan 17, 2006·12 cites·36 claims
- 1085US10272079B2NHE3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Apr 30, 2019·5 cites·15 claims
- 1185US8815910B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 26, 2014·7 cites·38 claims
- 1285US8815908B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2013·Granted Aug 26, 2014·7 cites·32 claims
- 1385US6852752B2Urea compounds, compositions and methods of use and preparationVICURON PHARM INC·Filed 2000·Granted Feb 8, 2005·17 cites·26 claims
- 1485US2025115608A1Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2024·Application pending·0 cites
- 1583US12281103B2Compounds useful for treating gastrointestinal tract disordersARDELYX INC·Filed 2023·Granted Apr 22, 2025·0 cites·17 claims
- 1683US10385024B2Compounds and methods for inhibiting NHE-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Granted Aug 20, 2019·3 cites·36 claims
- 1782US2024366589A1Nhe3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2024·Application pending·0 cites
- 1880US11091482B2Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activatorsARDELYX INC·Filed 2017·Granted Aug 17, 2021·3 cites·1 claims
- 1980US10392413B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2016·Granted Aug 27, 2019·3 cites·39 claims
- 2080US7199106B2Lincomycin derivatives possessing antimicrobial activityVICURON PHARM INC·Filed 2004·Granted Apr 3, 2007·11 cites·29 claims
- 2179US2025067907A1Compounds and methods for treating hyperkalemiaARDELYX INC·Filed 2024·Application pending·0 cites
- 2278US10940146B2NHE3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2019·Granted Mar 9, 2021·1 cites·4 claims
- 2377US12209088B2Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2022·Granted Jan 28, 2025·0 cites·20 claims
- 2477US7199105B2Lincomycin derivatives possessing antibacterial activityVICURON PHARM INC·Filed 2004·Granted Apr 3, 2007·8 cites·29 claims
- 2577US7164011B2Lincomycin derivatives possessing antibacterial activityVICURON PHARM INC·Filed 2003·Granted Jan 16, 2007·8 cites·29 claims
- 2676US7256177B2Lincomycin derivatives possessing antibacterial activityVICURON PHARM INC·Filed 2004·Granted Aug 14, 2007·8 cites·88 claims
- 2775US5705693ACationic lipidsGILEAD SCIENCES INC·Filed 1995·Granted Jan 6, 1998·16 cites·23 claims
- 2875US2023273354A1Glycyrrhetinic acid derivatives for treating hyperkalemiaARDELYX INC·Filed 2023·Application pending·0 cites
- 2975US2025263401A1Compounds useful for treating gastrointestinal tract disordersARDELYX INC·Filed 2025·Application pending·0 cites
- 3073US2022306610A1Compounds useful for treating gastrointestinal tract disordersARDELYX INC·Filed 2021·Application pending·0 cites
- 3172US2024209019A1Compounds and methods for treating hyperkalemiaARDELYX INC·Filed 2023·Application pending·0 cites
- 3271US12258332B2ASGPR cell surface receptor binding compounds and conjugatesLYCIA THERAPEUTICS INC·Filed 2023·Granted Mar 25, 2025·0 cites·18 claims
- 3371US2025101007A1Asgpr cell surface receptor binding compounds and conjugatesLYCIA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3470US2021186953A1Nhe3-binding compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2020·Application pending·0 cites
- 3569US11813304B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2019·Granted Nov 14, 2023·0 cites·14 claims
- 3669US2025388615A9Substituted 4-phenyl pyridine compounds as non-systemic tgr5 agonistsARDELYX INC·Filed 2024·Application pending·0 cites
- 3768US2021017177A1Hormone receptor modulators for treating metabolic conditions and disordersARDELYX INC·Filed 2020·Application pending·0 cites
- 3866US2024325487A1Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2023·Application pending·0 cites
- 3963US11718619B2Isoxazolyl-carbonyloxy azabicyclo[3.2.1]octanyl compounds as FXR activatorsARDELYX INC·Filed 2021·Granted Aug 8, 2023·0 cites·4 claims
- 4063US2019374533A1Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disordersARDELYX INC·Filed 2018·Application pending·0 cites
- 4162US9301951B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Apr 5, 2016·0 cites·40 claims
- 4262US2009149509A1Novel pyrrolidine bicyclic compounds and its derivatives, compositions and methods of useVICURON PHARM INC·Filed 2008·Application pending·0 cites
- 4359US11858959B2Glycyrrhetinic acid derivatives for use in treating hyperkalemiaARDELYX INC·Filed 2020·Granted Jan 2, 2024·0 cites·22 claims
- 4459US11768319B2Glycyrrhetinic acid derivatives for treating hyperkalemiaARDELYX INC·Filed 2018·Granted Sep 26, 2023·0 cites·18 claims
- 4559US7612059B2Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of useVICURON PHARM INC·Filed 2005·Granted Nov 3, 2009·0 cites·29 claims
- 4658US9289429B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 22, 2016·0 cites·33 claims
- 4758US9289430B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 22, 2016·0 cites·35 claims
- 4858US9278102B2Compounds and methods for inhibiting phosphate transportARDELYX INC·Filed 2014·Granted Mar 8, 2016·0 cites·29 claims
- 4956US12084472B2Substituted 4-phenyl pyridine compounds as non-systemic TGR5 agonistsARDELYX INC·Filed 2021·Granted Sep 10, 2024·0 cites·54 claims
- 5055US2024335544A1M6pr cell surface receptor binding compounds and conjugatesLYCIA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Showing the top 50 of 66 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jason G. Lewis files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →